Cargando…
Serum metabolomics analysis revealed metabolic disorders in Parkinson’s disease
Parkinson’s disease (PD) is by now the second of the most prevalent neurodegenerative diseases in the world, and its incidence is increasing rapidly as the global population ages, with 14.2 million PD patients expected worldwide by 2040. METHODS: We gathered a completion of 45 serum samples, includi...
Autores principales: | Lan, Tian-Tian, Chang, Le, Hou, Li-Wei, Wang, Zhen-Zhen, Li, Dong-Chu, Ren, Zi-Han, Gu, Tao, Wang, Jian-Wen, Chen, Gui-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256383/ https://www.ncbi.nlm.nih.gov/pubmed/37335671 http://dx.doi.org/10.1097/MD.0000000000033715 |
Ejemplares similares
-
Differential proteomic analysis of serum exosomes reveals alterations in progression of Parkinson disease
por: Jiang, Ruilai, et al.
Publicado: (2019) -
Cortical thickness in Parkinson disease: A coordinate-based meta-analysis
por: Sheng, LiQin, et al.
Publicado: (2020) -
Pseudohypoparathyroidism with basal ganglia calcification: A case report of rare cause of reversible parkinsonism
por: Song, Cheng-Yuan, et al.
Publicado: (2017) -
RNA-sequencing of peripheral blood circular RNAs in Parkinson disease
por: Kong, Fancong, et al.
Publicado: (2021) -
Blood neurofilament light chain in Parkinson disease and atypical parkinsonisms: A protocol for systematic review and meta-analysis
por: Wang, HongZhou, et al.
Publicado: (2020)